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Abstract
The health and survival of managed honey bee (Apis mellifera) colonies are affected 
by multiple factors, one of the most important being the interaction between viral 
pathogens and infestations of the ectoparasitic mite Varroa destructor. Currently, 
the only effective strategy available for mitigating the impact of viral infections is 
the chemical control of mite populations. Unfortunately, the use of in-hive acar-
icides comes at a price, as they can produce sublethal effects that are difficult to 
quantify, but may ultimately be as damaging as the mites they are used to treat. The 
goal of this study was to investigate the physiological and immunological effects of 
the formamidine acaricide amitraz and its primary metabolite in honey bees. Using 
flock house virus as a model for viral infection, this study found that exposure to a 
formamidine acaricide may have a negative impact on the ability of honey bees to 
tolerate viral infection. Furthermore, this work has demonstrated that amitraz and 
its metabolite significantly alter honey bee cardiac function, most likely through in-
teraction with octopamine receptors. The results suggest a potential drawback to 
the in-hive use of amitraz and raise intriguing questions about the relationship be-
tween insect cardiac function and disease tolerance. 
Keywords: Honey bee, Heart rate, Virus, Acaricide, Amitraz, DPMF, Octopamine, 
Phentolamine 
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1. Introduction 
The honey bee (Apis mellifera) is valued for providing economically 
and agriculturally important pollination services, as well as for pro-
viding honey and other natural products. Unacceptably high annual 
losses in the number of managed bee colonies in the United States 
(Seitz et al., 2016) have increased public awareness of pollinator health 
issues and focused research efforts on understanding why these losses 
occur. Although there exist a wide variety of factors that negatively 
affect pollinator health (Goulson et al., 2015), one of the most sig-
nificant threats to the survival of managed bee colonies is the risk of 
acute viral infections (Evans and Schwarz, 2011; Manley et al., 2015). 
The growing impact of viral infections is associated with the increased 
prevalence of the ectoparasitic mite Varroa destructor, which facili-
tates the spread of viral pathogens and weakens the immune respon-
siveness of bees, causing previously covert viral infections to become 
devastating outbreaks (Genersch and Aubert, 2010; Le Conte et al., 
2010; Nazzi et al., 2012). At this time, the only effective strategy that 
exists for minimizing the spread and impact of viral infections is the 
management of mite infestations, which relies heavily upon the use 
of apicultural acaricides such as the organophosphate coumaphos 
(Checkmite®), the pyrethroids tau-fluvalinate (Apistan®) and flume-
thrin (Bayvarol®), and the formamidine amitraz (Apivar®) (Rosen-
kranz et al., 2010). 
One of the most comprehensive surveys to date of agrochemicals 
associated with managed bee colonies in the United States found 
that acaricides used to control Varroa, or their associated metabo-
lites, are among the most ubiquitous contaminants of the hive envi-
ronment (Mullin et al., 2010). Although the acaricides coumaphos and 
tau-fluvalinate have decreased in effectiveness over the years, due 
to metabolic and target-site resistance in Varroa populations (Pet-
tis, 2004), they were the most common hive contaminants detected 
in the survey (Mullin et al., 2010), likely as a result of their continued 
use by beekeepers and their lipophilic nature, which allows them to 
persist in beeswax (Bogdanov, 2006). While amitraz does not persist 
in the hive environment (Martel et al., 2007), its metabolite N-(2,4-
dimethylphenyl)-N′-methylformamidine (DPMF) does accumulate and 
was among the ten most commonly detected pesticides in wax, pollen, 
and the bees themselves (Mullin et al., 2010). This finding is somewhat 
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surprising, as amitraz was withdrawn from commercial use in 1994 
and not registered for apicultural use at the time of the survey (John-
son et al., 2010), which suggests that it continued to be employed as 
a control measure in many areas. Since amitraz was reregistered for 
apicultural use by the Environmental Protection Agency in 2013, it is 
likely that its presence in the hive environment has increased. 
Amitraz is a formamidine acaricide that was originally marketed in 
the United States under the trade name Miticur®, until it was with-
drawn from commercial apicultural use. Amitraz, however, remained 
available as a veterinary acaricide under the trade name Taktic®, 
which was not labeled for apicultural use, until being reregistered un-
der the name Apivar®. Formamidines act as octopaminergic agonists 
in arthropods (Evans and Gee, 1980), suggesting that they are likely 
to influence honey bee behavior, learning, and memory formation, in 
addition to affecting physiological processes related to various tissues 
and sensory organs (Roeder, 2005). The biogenic monoamine octo-
pamine is understood to act as a neurotransmitter/neuromodulator 
in insects and other invertebrates, homologous to the noradrenergic 
system of vertebrates (Roeder, 1999). High levels of octopamine in the 
brain of honey bee workers can influence the division of labor within 
the colony (Schulz and Robinson, 2001) and affect foraging behavior 
(Barron et al., 2007). Stimulation of octopamine receptors improves 
kin recognition in honey bees (Robinson et al., 1999), and octopamine 
receptors appear to play a role in modulating honey bee hygienic be-
havior (Spivak et al., 2003). Octopamine, a known cardioaccelerant in 
insects, alters heart rate in isolated honey bee hearts (Papaefthimiou 
and Theophilidis, 2011), and the acaricide amitraz appears to have 
similar effects in this model (Papaefthimiou et al., 2013). Acute expo-
sure to amitraz has been shown to cause cell death in the midgut of 
honey bee larvae (Gregorc and Bowen, 2000), but does not appear to 
affect learning, short-term memory, or hemolymph octopamine lev-
els in honey bee workers (Rix and Cutler, 2017), nor has it been found 
to affect the survival or sperm viability of honey bee drones (John-
son et al., 2013). Though some acaricides have been found to reduce 
honey bee immunocompetence (Boncristiani et al., 2012; Locke et al., 
2012), amitraz was not observed to alter the expression profiles of a 
wide range of metabolic genes involved in detoxification, immunity, 
and development, nor did it appear to increase pathogen levels in 
treated honey bee colonies (Boncristiani et al., 2012). 
O’Neal  et  al .  in  Journal  of  Invertebrate  Pathology  149  (2017 )       4
At this time, no studies have been published that characterize the 
physiological or immunological effects of the amitraz metabolite 
DPMF in honey bees. Furthermore, little is known about the effect of 
formamidines, or any other class of pesticides, on the ability of bees 
to resist or tolerate viral infections. A number of challenges are as-
sociated with the study of viral infection in bees, including the high 
prevalence of covert, and often concurrent, viral infections in man-
aged colonies (Chen et al., 2004; de Miranda et al., 2010; Runckel et 
al., 2011), as well as a lack of availability of infectious clones of bee-
specific viruses. These factors pose a challenge for researchers focused 
on the outcome of infection with a single virus. While some research 
has been conducted using semi-purified virus preparations (Chen and 
Siede, 2007), complete removal of contaminating viruses is often im-
possible, making the accurate characterization of infection dynamics 
difficult. This represents a significant knowledge gap, given the im-
pact that viruses have on colony health and survival (Cox-Foster et al., 
2007; Johnson et al., 2009; McMenamin and Genersch, 2015), the ef-
fect of pesticide usage on pollinator health (Mullin et al., 2010), and 
concerns related to managed bee colony losses (Neumann and Car-
reck, 2010; Ratnieks and Carreck, 2010). The research described here 
will begin to address this gap by investigating the effect of amitraz 
and DPMF on the cardiac function of an agriculturally and economi-
cally important pollinator and model social insect. This work will then 
utilize a recently-described model virus system (O’Neal et al., 2017a) 
to assess the impact of amitraz and DPMF on the outcome of a viral 
infection in the honey bee. 
2. Materials and methods 
2.1. Subjects 
European honey bees (Apis mellifera) from colonies located at the Vir-
ginia Tech Price’s Fork Research Facility (Blacksburg, VA) apiary were 
used for all experiments. Colonies received no pesticide treatments or 
other exposure to in-hive chemical controls, but otherwise were main-
tained according to standard beekeeping practices for commercial 
hives. All bees that were housed in the lab overnight or longer were 
maintained in incubators at 32 °C with a relative humidity of 50–80%. 
For all dissection and heart rate assays, worker bees were collected 
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from brood frames during typical foraging times to ensure collection 
of predominately nurse bees. Any workers collected from the apiary 
that were housed in the lab incubators overnight were provided ad 
libitum access to honey and a 50% solution (w/v) of sucrose in wa-
ter. For all survival experiments, frames of emerging worker brood 
were removed from the hive and housed in a lab incubator in order 
to obtain age-matched cohorts of bees. Newly emerged bees were 
collected from these frames over the course of 24 h and housed in 
cages in groups of approximately 25 bees per cage with ad libitum 
access to a 50% solution (w/v) of sucrose in water. Cages were main-
tained in the incubator for the duration of the experiment and were 
provided with ¼ portions of a queen mandibular pheromone-impreg-
nated strip (Mann Lake Ltd.) to reduce stress by simulating the pres-
ence of an egg-laying queen. 
2.2. Dissection and heart rate assay 
Visualization and pharmacological manipulation of the honey bee 
heart, as well as measurements of heart rate, were conducted as pre-
viously described (O’Neal and Anderson, 2016; O’Neal et al., 2017b). 
Individual bees were dissected to separate the dorsal abdominal wall 
and expose the dorsal vessel, which was bathed in an isotonic solu-
tion (¼ strength Ringer’s solution; Sigma-Aldrich) and given time to 
allow the heartbeat to stabilize. Baseline heart rate was measured for 1 
min prior to treatment, then measured again 2 min later. All test com-
pounds were dissolved in dimethyl sulfoxide (DMSO) and then diluted 
in ¼ strength Ringer’s solution to prepare stock solutions. Test com-
pounds were prepared by serial dilution, ensuring a consistent vehicle 
of 1% DMSO in ¼ strength Ringer’s solution. Changes in heart rate 
were reported as percent change relative to the baseline heart rate, 
measured in beats per minute (BPM). 
2.3. Concentration response experiment 
The cardiomodulatory effects of the formamidine acaricide amitraz 
and its primary metabolite DPMF on bee heart rate were evaluated by 
testing a range of concentrations for each compound, along with the 
insect neurotransmitter/neuromodulator octopamine and the octo-
pamine receptor antagonist phentolamine. All test compounds were 
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obtained from Sigma-Aldrich at the highest purity available and pre-
pared and delivered in 1% DMSO in ¼ strength Ringer’s solution, 
which served as the vehicle control. Test compounds were evaluated 
across a range of concentrations spanning the high nanomolar to the 
low millimolar in order to establish a profile for each compound. The 
sample size for each treatment group consisted of 10 individual bee 
dissections. 
2.4. Phentolamine pretreatment experiment 
The ability of amitraz and its metabolite DPMF to modulate honey bee 
heart rate via interaction with octopamine receptors was examined to 
determine if phentolamine, a specific octopamine receptor antago-
nist in insects, including honey bees (Degen et al., 2000), could block 
their effects. Based on the results of the previous experiment, 100 nM 
phentolamine was selected to test against 100 μM octopamine, am-
itraz, and DPMF. Phentolamine was tested at the highest concentra-
tion that did not produce a significant effect on heart rate. The con-
centrations of octopamine, amitraz, and DPMF were selected due to 
their significant effect on heart rate. The dissection and pharmaco-
logical manipulation assay remained unchanged, except that follow-
ing dissection and visualization, the heart was bathed in either vehicle 
or vehicle containing 100 nM phentolamine. The protocol then con-
tinued as previously described, with the application of 100 μM octo-
pamine, amitraz, DPMF, or vehicle control following 1 min of base-
line heart rate assessment. The sample size for each treatment group 
consisted of 12 individual bee dissections. 
2.5. Acaricide exposure 
Bees were exposed to acaricides either through oral administration or 
exposure to a portion of an Apivar® Miticide Strip (Mann Lake Ltd.) 
in the cage. For oral administration, stock solutions of amitraz and 
DPMF (Sigma-Aldrich) were initially prepared in DMSO. Test groups 
received 50% sucrose solution (w/v) supplemented with either am-
itraz or DPMF (100 μM final concentration) in DMSO (1% final con-
centration), while vehicle control groups received sucrose solution 
supplemented only with 1% DMSO. In order to avoid complications 
related to the poor solubility of amitraz, supplemented solutions were 
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prepared fresh daily. The concentration of amitraz and DPMF (100 μM) 
was selected based on preliminary testing, which revealed this to be 
the highest concentration of either compound that did not signifi-
cantly affect bee survival over a 10 d period. Preliminary testing also 
demonstrated no significant effects of sucrose solution supplemented 
with 1% DMSO on bee survival over a 10 d period. In order to simu-
late the type of exposure that bees would typically have to an in-hive 
acaricide treatment, test cages were equipped with a 0.5 cm × 4 cm 
portion of an amitraz-impregnated acaricide strip (3.33% active ingre-
dient). Preliminary testing demonstrated that the presence of the acar-
icide strip did not have any effect on bee survival over a 10 d period. 
2.6. Viral infection 
Viral infections were performed using flock house virus (FHV), gener-
ously provided by Dr. Anette Schneemann (The Scripps Research In-
stitute, La Jolla, California), that was purified as previously described 
(Marshall and Schneemann, 2001). FHV has been shown to pathogen-
ically infect honey bees and has been used as a model for the study 
of viral infections in bees (O’Neal et al., 2017a). Viral stocks were pre-
pared in 10 mM Tris-HCl, pH 7.5. Infections were performed by injec-
tion (Nanoject II apparatus; Drummond Scientific) of 50.6 nl of a 2×107 
plaque-forming units (pfu)/μl viral suspension into the thorax of each 
bee, resulting in the delivery of 1×106 pfu of FHV/bee. This virus titer 
was selected based on previous work (O’Neal et al., 2017a), which sug-
gested that it would produce a moderate infection that would permit 
the observation of changes in survival over time in different treatment 
groups. Injection of the same volume of 10 mM Tris-HCl, pH 7.5, was 
used as a vehicle control. Preliminary testing compared the survival of 
bees following vehicle control injections and sham injections, in which 
the bee thorax was punctured by the needle without delivery of fluid, 
and found that neither group experienced significant changes in sur-
vival relative to uninjected bees over a 10 d period. 
2.7. Oral dosing survival experiment 
The effects of amitraz and its metabolite DPMF on the survival of vi-
rus-challenged honey bees was examined by orally exposing individ-
uals to these compounds and then infecting them with FHV. For all 
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survival experiments, six replicates of 25 bees each were used for each 
treatment group. Bees were injected with either vehicle or virus follow-
ing 24 h of exposure to amitraz-supplemented, DPMF-supplemented, 
or DMSO-supplemented sucrose solution as the only source of food 
and water. Bees were provided access to the same sucrose solution, 
which was prepared fresh each day, for the duration of the test. Sur-
vival was observed daily following injection for 10 d. 
2.8. Acaricide strip survival experiment 
The effects of contact exposure to amitraz on the survival of virus-
challenged honey bees was examined by exposing bees to an ami-
traz-impregnated plastic strip, a commonly-used treatment in mite-
infested hives, and then infecting them with FHV. As in the previous 
survival experiments, six replicates of 25 bees each were used for each 
treatment group. Bees were injected with either vehicle or virus fol-
lowing 24 h of exposure to the amitraz strip and remained exposed to 
the strip throughout the duration of the test. Survival was observed 
daily following injection for 5 d. 
2.9. Statistical analysis 
All heart rate assay analyses and calculations were conducted using 
GraphPad Prism 7 (GraphPad Software, Inc., La Jolla, CA). All heart rate 
assay results are expressed as the mean ± standard deviation (SD). 
Each heart rate assay treatment group was subjected to a D’Agostino-
Pearson test for normality (P < 0.05) and not all groups were found to 
come from a normally distributed population; therefore, a nonpara-
metric, two-tailed Mann-Whitney test (P < 0.05) was used for all com-
parisons between heart rate assay treatment groups. A one-way anal-
ysis of variance (ANOVA) was used to test for differences (P < 0.05) in 
the mean baseline heart rate of groups in the concentration response 
experiment. All survival experiment results are reported as Kaplan-
Meier survival curves, calculated using GraphPad Prism 7, with signif-
icant differences between the survival curves determined by the log-
rank (Mantel-Cox) test. For the acaricide strip survival experiment, the 
treatment mortality (Untreated/Virus and Amitraz/Virus) was corrected 
for control mortality (Untreated/Vehicle and Amitraz/Vehicle) using 
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Abbott’s formula (Abbott, 1925). A mixed model repeated-measures 
analysis of the corrected mortality data was performed as previously 
described (Singh et al., 2016) using JMP Version 13 (SAS Institute Inc., 
Cary, NC) to determine differences between treatments and their in-
teraction with time. In the model, treatment, day, and treatment by 
day were the fixed effects and replicate was the random effect. 
3. Results 
3.1. Concentration response experiment 
Phentolamine treatment decreased honey bee heart rate, whereas oc-
topamine, amitraz, and DPMF treatment increased heart rate (Fig. 1). 
Phentolamine produced a concentration-dependent effect on heart 
rate, as the application of increasing concentrations resulted in greater 
decreases in heart rate with no evidence of an increase at any con-
centration. A significant decrease in heart rate relative to the vehicle 
control was observed at concentrations of 300 nM and above (Mann-
Whitney test; P< 0.01) with maximal effect (complete cessation of 
heart beat) observed at 1 mM. Mean baseline heart rate (±SD) across 
phentolamine treatment groups was 105.0 ± 2.5 BPM. Octopamine 
significantly increased heart rate relative to the vehicle control at con-
centrations of 3 μM and above (Mann-Whitney test; P <0.01). Mean 
baseline heart rate (±SD) across octopamine treatment groups was 
101.7 ± 9.6 BPM. Amitraz significantly increased heart rate relative 
to the vehicle control at concentrations of 30 μM and above (Mann-
Whitney test; P <0.01). Mean baseline heart rate (±SD) across amitraz 
treatment groups was 102.8 ±4.7 BPM. DPMF significantly increased 
heart rate relative to the vehicle control at concentrations of 1 μM 
and above (Mann-Whitney test; P < 0.01). Mean baseline heart rate 
(±SD) across DPMF treatment groups was 105.4 ± 3.1 BPM. Maximal 
effects could not be determined for octopamine, amitraz, and DPMF 
due to solubility issues at concentrations greater than 1 mM. No sta-
tistically significant differences were detected between the mean base-
line heart rates of each experimental group.  
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3.2. Phentolamine pretreatment experiment 
Pretreatment with phentolamine uniformly blocked the cardioaccel-
eratory effects of octopamine, amitraz, and DPMF (Fig. 2). Pretreat-
ment with 100 nM phentolamine followed by treatment with vehicle 
resulted in no significant change in heart rate relative to the vehicle 
Fig. 1. Percent change in heart rate (beats per minute, BPM) resulting from the ap-
plication of increasing concentrations of amitraz, DPMF, octopamine, and phentol-
amine. Bars represent mean change in heartbeat frequency ± standard deviation 
relative to baseline heart rate (n = 10). The mean treatment values were compared 
to a vehicle control using a nonparametric Mann-Whitney test where P < 0.05 was 
considered significant, as represented by *. Data were analyzed using GraphPad 
Prism 7 software.  
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control. Pretreatment with vehicle followed by 100 μM octopamine, 
100 μM amitraz, or 100 μM DPMF resulted in a significant increase in 
heart rate (Mann-Whitney test; P < 0.001), with effects comparable to 
what was observed in the previous experiment (Fig. 1). Pretreatment 
with 100 nM phentolamine followed by treatment with 100 μM octo-
pamine, 100 μM amitraz, or 100 μM DPMF resulted in a complete loss 
of effect, with the observed heart rate not significantly different from 
vehicle treatment, but significantly reduced when compared to the 
corresponding drug-treated replicates without phentolamine (Mann-
Whitney test; P< 0.01). Mean baseline heart rate (±SD) across treat-
ment groups measured 98.0 ± 2.7 BPM. 
Fig. 2. Percent change in heart rate (beats per minute, BPM) resulting from the ap-
plication of phentolamine followed by octopamine, amitraz, or DPMF. Bars repre-
sent mean change in heartbeat frequency ± standard deviation relative to baseline 
heart rate (n =12). The mean values were compared using a nonparametric Mann-
Whitney test where P < 0.05 was considered significant. * indicates a significant dif-
ference from VEH/VEH group. ** indicates no significant difference from VEH/VEH, 
but a significant difference from VEH/OCT. *** indicates no significant difference 
from VEH/VEH, but a significant difference from VEH/AMZ. **** indicates no signif-
icant difference from VEH/VEH, but a significant difference from VEH/DPM. Data 
were analyzed using GraphPad Prism 7 software.  
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3.3. Oral dosing survival experiment 
Treatment with amitraz and the amitraz metabolite DPMF decreased 
the survival of honey bees following infection with 1×106 pfu of FHV/
bee, relative to the infected control group (Fig. 3). Bees in the un-
infected control groups all experienced approximately 10% mortal-
ity by 5 d post-injection and 25% mortality by the end of the study 
at 10 d post-injection. Infected controls experienced 46% mortality 
by 5 d postinjection and reached 100% mortality at 9 d post-injec-
tion, whereas infected bees receiving amitraz treatment experienced 
83% mortality by 5 d post-injection and reached 100% mortality at 
7 d post-injection. Similarly, infected bees receiving DPMF treatment 
experienced 75% mortality by 5 d post-injection and reached 100% 
mortality at 7 d postinjection. Log-rank tests of the Kaplan–Meier sur-
vival curves indicated a significant difference in survival between in-
fected bees that were treated with amitraz and infected bees that were 
treated with vehicle (χ2 = 54.32; df = 1; P < 0.0001). Similarly, a signif-
icant difference in survival was also detected between infected bees 
Fig. 3. Effect of orally-dosed amitraz and its metabolite DPMF on honey bee survival 
following a virus challenge. Data presented as Kaplan-Meier survival curves with 
points representing mean values ± standard error for 150 bees (6 replicate groups 
of 25 adult bees each per treatment). Amitraz/Virus and DPMF/Virus groups expe-
rienced significantly higher mortality than Control/Virus group (Kaplan-Meier log-
rank test; P < 0.0001). Data were analyzed using GraphPad Prism 7 software.  
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that were treated with DPMF and infected bees that were treated with 
vehicle (χ2 = 41.45; df = 1; P < 0.0001). There was no significant dif-
ference in survival detected between the uninfected control groups 
treated with vehicle, amitraz, or DPMF, nor was there any difference 
between the infected groups treated with amitraz and DPMF. 
3.4. Acaricide strip survival experiment 
Exposure to amitraz-impregnated plastic strips decreased the sur-
vival of bees challenged with virus and vehicle injections alike, rela-
tive to the respective control groups (Fig. 4). Infected bees exposed 
to amitraz experienced 85% mortality just 1 d after infection, com-
pared to only 10% for the infected control group. Bees injected with 
vehicle and exposed to amitraz experienced 32% mortality after just 
1 d, compared to only 1% mortality for the uninfected control group. 
Infected bees exposed to amitraz experienced 100% mortality by 3 
d after injection, whereas the curve leveled off for bees injected with 
Fig. 4. Effect of exposure to Apivar® (amitraz) strips on honey bee survival follow-
ing a virus challenge. Data presented as Kaplan-Meier survival curves with points 
representing mean values ± standard error for 150 bees (6 replicate groups of 25 
adult bees each per treatment). The Amitraz/Virus group experienced significantly 
higher mortality than all other groups, while Amitraz/Vehicle and Control/Virus did 
not differ from one another, but both experienced greater mortality than Control/
Vehicle (Kaplan-Meier log-rank test; P <0.0001). Data were analyzed using Graph-
Pad Prism 7 software.   
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vehicle and exposed to amitraz starting at 2 d after injection and 
their survival remained consistent at approximately 40% mortality 
for the remainder of the study. Log-rank tests of the Kaplan–Meier 
survival curves indicated a significant difference in survival between 
the Untreated/Vehicle and Untreated/Virus groups (χ2 = 44.43; df = 
1; P < 0.0001), between the Untreated/Vehicle and Amitraz/Vehicle 
groups (χ2 = 43.57; df = 1; P < 0.0001), and between the Untreated/
Vehicle and Amitraz/Virus groups (χ2 = 329.20; df = 1; P < 0.0001). 
Significant differences were also detected between the Untreated/
Virus and Amitraz/Virus groups (χ2 = 240.70; df= 1; P < 0.0001) and 
between the Amitraz/Vehicle and Amitraz/Virus groups (χ2 = 147.90; 
df = 1; P < 0.0001), but no difference was detected between the Un-
treated/Virus and Amitraz/Vehicle groups. When the treatment mor-
tality was corrected for the control mortality, amitraz was found to 
have a significant effect on the survival of virus-infected bees (F = 
1997.39; df = 1, 13; P <0.0001). 
4. Discussion 
This work has demonstrated that the formamidine acaricide amitraz 
and its metabolite DPMF significantly alter honey bee cardiac function, 
most likely through interaction with octopamine receptors. Treatment 
with the octopamine receptor antagonist phentolamine decreased 
honey bee heart rate, whereas treatment with octopamine, amitraz, 
and DPMF increased heart rate. Furthermore, pretreatment with a low 
concentration of phentolamine was found to block the effects of oc-
topamine, amitraz and DPMF. This work has also demonstrated that 
exposure to a formamidine acaricide may have a negative impact on 
the ability of honey bees to tolerate viral infection. Oral treatment 
with amitraz and DPMF similarly decreased the survival of virus-chal-
lenged bees, as did exposure to amitraz-impregnated plastic strips 
routinely used in the treatment of mite-infested hives. These findings 
are significant as they highlight the complex nature of insect immu-
nity and disease tolerance, as well as the inter-relatedness of diverse 
physiological systems. 
The changes in heart rate observed with this approach are com-
parable in many respects to those observed using other methods, 
most notably two studies that tested the effects of octopamine, 
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phentolamine, and amitraz on ex vivo honey bee heart preparations 
using a force-displacement transducer and intracellular recordings of 
heart muscle fibers using microelectrodes (Papaefthimiou et al., 2013; 
Papaefthimiou and Theophilidis, 2011). In these studies, octopamine 
was observed to have a cardioacceleratory effect in bees at concentra-
tions in the picomolar range and above, while phentolamine blocked 
contractions in the micromolar range (Papaefthimiou and Theophi-
lidis, 2011). Amitraz was also observed to have a cardioacceleratory 
effect on ex vivo bee hearts at concentrations in the nanomolar and 
micromolar ranges and above, as well as in experiments examining 
in vivo effects via injection or oral administration (Papaefthimiou et 
al., 2013). These studies, however, reported biphasic effects of both 
octopamine and amitraz, noting that at lower concentrations, both 
compounds could have inhibitory effects. Octopamine was reported 
to act as an antagonist in the femtomolar range (Papaefthimiou and 
Theophilidis, 2011), suggesting extreme sensitivity of the bee heart, 
though even the authors acknowledge that this might be unrealisti-
cally low. Amitraz was observed to have inhibitory effects on bee car-
diac activity at concentrations in the picomolar range, while at higher 
concentrations, an initial inhibitory response preceded the observed 
cardioacceleration (Papaefthimiou et al., 2013). 
The biphasic effects and the extremely high sensitivity detected in 
these two studies may be due in part to the significant differences 
between the recording methods used in these studies and the work 
reported here. Another significant difference, however, is that both 
of these studies reported that recordings of ex vivo heart prepara-
tions did not begin until an hour or more following dissection, dur-
ing which time significant changes in bee heart rate were reported to 
take place (Papaefthimiou and Theophilidis, 2011), resulting in the de-
velopment of a bursting pattern that appears quite different from the 
steady heart rate observed using the method reported here. Although 
the dissection and visualization method employed in this work (O’Neal 
and Anderson, 2016) has been observed to allow heart preparations 
to continue beating for two hours or more, provided periodic renewal 
of the isotonic solution bathing the heart, qualitative differences sug-
gesting tissue degradation can be observed, in addition to slowing 
of heart rate and localized or partial loss of heart function. To avoid 
this, observations of heart rate typically began within approximately 
5 min of dissection, which provided sufficient time for the heart rate 
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to stabilize. Consequently, these differences in the observed effects of 
octopamine and amitraz are likely due to the significant differences in 
methodology employed. As DPMF has not been previously tested in 
a similar model, no such comparisons can be made. 
Exposure to cardiomodulatory compounds such as amitraz can 
have a significant impact on a variety of physiological processes, as 
the insect circulatory system is understood to play a role in thermo-
regulation, ventilation, and the maintenance of homeostasis. Several 
studies have also found that insect circulatory and immune systems 
can closely interact to regulate infections (King and Hillyer, 2012; Si-
gle and Hillyer, 2016), reinforcing the idea that there exists an exten-
sive level of integration between cardiac function and the insect im-
mune response. The primary insect antiviral immune response is the 
post-transcriptional gene silencing mechanism known as RNA interfer-
ence (RNAi), which initiates targeted degradation of RNA in response 
to the presence of double-stranded RNA (dsRNA) (Ding, 2010; Ding 
and Voinnet, 2007). While bees have been shown to employ an anti-
viral RNAi response (Chejanovsky et al., 2014; Desai et al., 2012; Maori 
et al., 2009; Wang et al., 2013), there is also evidence that the pres-
ence of nonspecific dsRNA is sufficient to reduce virus production in 
bees (Flenniken and Andino, 2013). Another difference noted during 
a comprehensive examination of honey bee immune responses is that 
bees were found to only express about one third as many genes as-
sociated with insect immunity as have been observed in fruit flies and 
mosquitoes (Evans et al., 2006). One explanation for this discrepancy 
could be the effectiveness of colony-level, social immune barriers to 
infection. Another possibility is that bees also rely on tissue-specific, 
homeostatic mechanisms to simply tolerate infection (Schneider and 
Ayres, 2008). This idea is supported by findings that demonstrate an 
essential role for the evolutionarily conserved cardiac ion channel 
known as the ATP-sensitive inwardly rectifying potassium (KATP) chan-
nel in the resistance to infection by a cardiotropic virus in Drosophila, 
through modulation of RNAi (Eleftherianos et al., 2011). More recent 
work has provided evidence of KATP channel regulation of viral infec-
tions in bees (O’Neal et al., 2017a) and proposed an important role 
for this ion channel in connecting the antiviral immune response of 
bees to changes in cellular metabolism induced by exposure to envi-
ronmental stressors. 
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It is understood that exposure to chronic stress gradually weakens 
the immune response and reduces the metabolic activity of an organ-
ism until it is no longer able to survive (McEwen, 2000). This holds 
true for bees as well, since physiological stress can have a wide range 
of detrimental consequences for bee health and survival (Even et al., 
2012). Harmful synergistic interactions between simultaneous expo-
sure to pesticides, dietary toxins, and pathogens have been demon-
strated in bees, though the specific mechanisms that explain these 
interactions have yet to be revealed (Alaux et al., 2010; Aufauvre et 
al., 2012; Kohler et al., 2012; Vidau et al., 2011). Especially relevant to 
managed colony health is the evidence that apicultural pesticides can 
negatively impact bee immunity, as the acaricide tau-fluvalinate has 
been shown to have an effect on host susceptibility to viral infection 
(Locke et al., 2012), while the acaricides thymol, coumaphos, and for-
mic acid were found to alter the expression of genes related to immu-
nity, detoxification, and development (Boncristiani et al., 2012). The 
work presented here provides the first evidence that the formamidine 
acaricide amitraz, as well as its primary metabolite DPMF, may have 
a negative impact on honey bee antiviral resistance or tolerance to 
viral infection. This work also demonstrates the physiological effect 
that amitraz and DPMF can have on bee cardiac function, describing 
a cardioacceleratory role for both. 
Although these findings do not provide direct evidence of a rela-
tionship between octopamine receptor-mediated modulation of bee 
cardiac function and weakened immunity or tolerance to viral infec-
tion, it is reasonable to hypothesize that such a relationship could ex-
ist, given the integration between insect immune and circulatory sys-
tems, as well as the important role of cardiac function in maintaining 
homeostasis. These findings demonstrate that DPMF is at least as car-
dioactive as the parent compound amitraz and appears to function 
in the same manner as amitraz, as the activity of each is blocked by 
the octopamine receptor antagonist phentolamine. This is important 
to note, as amitraz is quickly metabolized, but DPMF is less easily de-
graded and is one of the most commonly encountered agrochemical 
contaminants in the hive environment, as well as the bees themselves 
(Mullin et al., 2010). This means that managed bees may experience 
long-term exposure to residual DPMF present in the hive, even after 
amitraz treatment has been discontinued. This is significant, given 
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that this study reveals a potentially harmful synergistic relationship 
between exposure to amitraz, as well as DPMF, and the ability to re-
sist or tolerate a viral infection. Although these findings are signifi-
cant and dramatic, it can be argued that this experimental approach 
does not truly reflect the typical exposure of bees during an in-hive 
treatment with amitraz. 
In order to simulate in-hive amitraz treatment, caged bees were ex-
posed to small portions of a commercial miticide strip impregnated 
with amitraz. While preliminary testing found that this type of expo-
sure had no effect on the survival of caged bees, this treatment did 
have a significant effect on the survival of bees challenged with virus, 
as well as bees in the control group that were challenged with a ve-
hicle injection. The effects are quite pronounced after just 1 d post-
injection, as there was considerable mortality in both the amitraz-
treated groups. Interestingly, mortality levels off at that point in the 
amitraz-treated group that received a vehicle challenge, whereas the 
rate of mortality continues in both virus-challenged groups. It is very 
likely that this observation is related to the age of the bees, which had 
eclosed between 24 and 48 h prior to injection. One possibility is that 
the cuticular layers were still in a state of transition following eclosion, 
making the cuticle more susceptible to penetration by amitraz during 
this state (Noble-Nesbitt, 1970). Another possibility is that cuticular 
injury from the injection also facilitated amitraz penetration. In either 
case, however, there appears to be a synergistic interaction between 
exposure to amitraz and either the vehicle or the injury from the in-
jection, which could imply that there is a trade-off, or a competition 
for resources, that limits the ability of the bee to both detoxify the 
acaricide and respond to the injury. This interaction warrants a more 
thorough examination. 
These findings have some immediate implications for apiculture 
practices, as there is likely a trade-off to be considered when the de-
cision is being made to treat a mite-infested hive with amitraz. Unfor-
tunately, the data provided here are insufficient for determining when 
the economic benefits of treating with amitraz outweigh the possi-
ble drawbacks of reducing immune responsiveness. More research 
is needed to determine the practical implications of the interactions 
between amitraz, DPMF, and honey bee resistance or tolerance to vi-
ral infection at the colony level, but the evidence supports a policy 
O’Neal  et  al .  in  Journal  of  Invertebrate  Pathology  149  (2017 )      19
of minimizing chemical interventions within the hive. These findings 
also raise intriguing questions about the nature of this interaction. Is 
this relationship the result of octopaminergic interference with car-
diac function, thereby resulting in a loss of homeostasis and the abil-
ity to tolerate infection? Or, do these compounds act through some 
unknown mechanism to regulate the innate immune response of the 
insect? Furthermore, are there age-dependent effects that must also 
be considered here? The answers to these questions would provide 
significant insight into honey bee physiology and represent a prom-
ising area for future research intended to improve understanding of 
honey bee antiviral immunity, disease tolerance, and their relation-
ship to factors that negatively impact pollinator health.  
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